针对MCR-1耐药菌株,OBOC对高活性和低毒性聚米辛类型的查
Wenhong Zheng1,2, Xin Wang1,2, Hao Lian2,3
1School of Bioscience and Technology Shandong Second Medical University Weifang, Shandong 261053, China. lill@bit.edu.cn.
Biomaterials science
|April 3, 2025
概括
研究人员使用逆合成和OBOC技术制造了1152种多素B类型. 两种类型显示出高抗菌活性和提高了安全性,为抗生素开发提供了结构-活性关系的新见解.
科学领域:
- 药用化学 医学化学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 聚米辛B是一种关键的抗生素,用于治疗多药耐药的格拉姆阴性细菌感染.
- 由于抗菌素耐药性日益增加,开发新型聚米辛类型的发展至关重要.
- 修改水友性和电荷特性可能会影响聚胺的有效性和安全性.
研究的目的:
- 合成多种多样的polymyxin B结构类似物库.
- 识别具有增强抗菌活性和改进安全概况的新型聚米辛衍生物.
- 为了深入了解聚米辛类型的结构-活性关系.
主要方法:
- 采用逆合成策略来产生结构类比.
- 采用了一个珠-一个化合物 (OBOC) 组合化学技术.
- 合成化合物的评估抗菌活性和安全窗口.
主要成果:
- 成功合成了聚米辛B的1152种结构模拟物.
- 确定了两种化合物,显示出强大的抗菌疗效.
- 在确定候选人的安全窗口中实现了 4-16 倍的扩展.
- 阐明了关键的结构-活动关系,以指导进一步的模拟设计.
结论:
- 反向合成与OBOC技术相结合,可以有效地产生多素B类型.
- 可以开发出新型的聚米辛类型,以提高安全性并保持高抗菌活性.
- 这些已识别的化合物代表了对抗抗性细菌感染的有希望的候选物.
相关概念视频
01:25Mechanism of Antibiotic Resistance in MRSA
135
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
135
01:25Clinical Significance of Antibiotic Resistance
55
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
55